Oxford lab wins £6M for Parkinson's Disease research
- 6 March 2015
Researchers at Oxford University have been awarded a £6 million grant for their cutting-edge research programme on finding drug targets for Parkinson's Disease. This new funding builds on an initial £5M investment from Parkinson’s UK to researchers at the Oxford Parkinson’s Disease Centre (OPDC) in 2010.
One in 500 people in Oxfordshire have Parkinson's – a neurological condition which can leave people struggling to walk, speak and sleep, and which has no cure.
By 2020 the multidisciplinary team at Oxford hopes to use the £6 million to find new drugs to slow, or even stop Parkinson's, using a 'brain cell bank' they have developed to identify promising new drug targets. They also want to improve how to diagnose and monitor Parkinson's using new technology, such as smartphone apps.